Davis Polk advised Privia Health Group on the offering. Privia Health Group, Inc. announced its secondary offering of 6,000,000 shares of common stock by certain selling...
Privia Health’s $174 Million Shares Secondary Offering
Marsh McLennan’s $750 Million Senior Notes Offering
Willkie Farr & Gallagher represented the joint book-running managers in the offering. Davis Polk advised Marsh McLennan. Marsh McLennan announced that it priced $400 million aggregate...
IVERIC bio’s $173.4 Million Stock Offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters in the offering. IVERIC bio Inc. executed a $173.4 million SEC-registered offering of 10,350,000 shares...
Match Group’s Stock and Notes Offering
Davis Polk advised Match Group on the offering. Match Group, Inc executed its offering of shares of its common stock for an aggregate amount of $879 million...
Home Depot’s $3 Billion Notes Offering
Davis Polk advised the representatives of the several underwriters in the offering. The Home Depot, Inc. executed its offering of $1 billion aggregate principal amount of 1.500%...
BRP Group’s $280.6 Million Follow-on Stock Offering
Davis Polk advised BRP Group on the deal. BRP Group, Inc. executed its $280.6 million follow-on offering of 9,200,000 shares of Class A common stock, which...
Metropolitan Bank Holding Corp.’s $172.5 Shares Offering
Luse Gorman advised Metropolitan Bank Holding Corp. on the deal, while Davis Polk advised the joint book-running managers. Metropolitan Bank Holding Corp., New York, New York,...
Hamilton Lane’s $80 Million Shares Offering
Davis Polk advised the book-running manager, Morgan Stanley & Co., in the offering. Hamilton Lane Incorporated executed its $80 million SEC-registered follow-on offering of 950,751 shares of...
MSCI’s $700 Million Notes Offering
Davis Polk advised MSCI Inc. in the offering, while Cahill represented the initial purchasers. MSCI Inc. executed its offering of $700 million aggregate principal amount of...
Adagio Therapeutics’ $356 Million Initial Public Offering
Davis Polk advised the representatives of the several underwriters in the offering. Adagio Therapeutics, Inc. executed the initial public offering of 20,930,000 shares of its common stock at...
Royalty Pharma’s $1.3 Billion Senior Notes Offering
Davis Polk advised Royalty Pharma plc on the transaction. Royalty Pharma executed its offering of $1.3 billion aggregate principal amount of senior notes. The offering consisted of...
Gatos Silver’s $160 Million Shares Offering
Davis Polk advised Gatos Silver on the deal. Gatos Silver, Inc. executed an SEC-registered follow-on equity offering of 11,430,000 shares of common stock, including 2,500,000 shares...